✨
AI Summary
- Sekar Kathiresan on Verve Therapeutics' gene editing for heart disease.
- Explores a single-shot treatment targeting cardiovascular risk.
- Takeaway: Gene editing offers a novel approach to chronic disease.
Guests on This Episode
SK
Sekar Kathiresan
1 podcast appearance